Y. Qian, A. Vogt, S. M. Sebti, and A. D. Hamilton.
Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferases inhibitors.
Journal of Medicinal Chemistry 1996, 39(1), 217-223.
DOI: 10.1021/jm950414g
Y. Hamuro, S. J. Geib, and A. D. Hamilton.
Oligoanthranilamides. Non-peptide subunits that show formation of specific secondary structure.
Journal of the American Chemical Society 1996, 118(32), 7529-7541.
DOI: 10.1021/ja9539857
S. M. Sebti and A. D. Hamilton.
Rational design of Ras prenyl transferase inhibitors as potential anticancer drugs.
Biochemical Society Transactions 1996, 24(3), 692-699.
DOI: 10.1042/bst0240692
J. R. Fredericks and A. D. Hamilton.
Metal template control of self-assembly in supramolecular chemistry.
In Perspectives in Supramolecular Chemistry, volume 3, pages 1-39. John Wiley & Sons, 1996.
E. J. Bernhard, G. Kao, A. D. Cox, S. M. Sebti, A. D. Hamilton, R. J. Muschel, and W. G. McKenna.
The farnesyltransferase inhibitor fti-277 radiosensitizes H-ras-transformed rat embryo fibroblasts.
Cancer Research 1996, 56(8), 1727-1730.
A. Zafar, J. Yang, S. J. Geib, and A. D. Hamilton.
Linked bis-isophthalic acid derivatives as building blocks in the design of ordered solids.
Tetrahedron Letters 1996, 37(14), 2327-2330.
DOI: 10.1016/0040-4039(96)00287-0
J. R. Fredericks and A. D. Hamilton.
Hydrogen bonding control of molecular self-assembly: Recent advances in design, synthesis, and analysis.
In J. P. Sauvage and M. W. Hosseini, editors, Comprehensive Supramolecular Chemistry, volume 9, pages 565-94, Oxford. Pergamon Press.
B. Linton, M. S. Goodman, V. Jubian, and A. D. Hamilton.
Self-assembly as a strategy for artificial receptor design.
In J. Wuest, editor, Self-Assembly in Synthetic Chemistry. Klewer, 1996.
R. B. Hopkins, J. S. Albert, D. Van Engen, and A. D. Hamilton.
Synthesis and structure of chiral mocrocycles containing 2,2'-bipyridine subunits
Bioorganic and Medicinal Chemistry 1996, 4(7), 1121-1128.
DOI: 10.1016/0968-0896(96)00124-1
A. Vogt, Y. Qian, T. F. McGuire, M. A. Blaskovitch, A. D. Hamilton, and S. M. Sebti.
Protein geranylgeranylation, not farnesylation, is required for G1 to S phase transition in mouse fibroblasts.
Oncogene 1996, 13(9), 1991-1999.
T. F. McGuire, Y. Qian, A. Vogt, A. D. Hamilton, and S. M. Sebti.
Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation.
Journal of Biological Chemistry 1996, 271(44), 27402-27407.
DOI: 10.1074/jbc.271.44.27402
C. J. Der, A. D. Cox, S. M. Sebti, and A. D. Hamilton.
Farnesyltransferase inhibitors: Anti-ras drugs for cancer treatment.
Anti-Cancer Drugs 1996, 7, 165.